Sonia Guedan's candidacy recognizes her advances in the development of new generation CAR-T to treat cancer, one of the current great frontiers of immunotherapy. Her work opens new avenues to increase the efficacy and safety of this type of therapy, and represents a step forward towards more personalized and effective treatments.
The prize is awarded by popular vote and can be voted on until June 30. We encourage you to support the candidacy through the following link.
